Cargando…
Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases
Respiratory syncytial virus (RSV) is often the first clinically relevant pathogen encountered in life, with nearly all children infected by two years of age. Many studies have also linked early-life severe respiratory viral infection with more pathogenic immune responses later in life that lead to p...
Autores principales: | Malinczak, Carrie-Anne, Lukacs, Nicholas W., Fonseca, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290378/ https://www.ncbi.nlm.nih.gov/pubmed/32375305 http://dx.doi.org/10.3390/v12050505 |
Ejemplares similares
-
Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
por: Lukacs, Nicholas W., et al.
Publicado: (2020) -
Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection
por: Yagi, Kazuma, et al.
Publicado: (2022) -
Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome
por: Fonseca, Wendy, et al.
Publicado: (2018) -
Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease
por: Malinczak, Carrie-Anne, et al.
Publicado: (2019) -
Role of ILC2 in Viral-Induced Lung Pathogenesis
por: Fonseca, Wendy, et al.
Publicado: (2021)